chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Flatulence, Pyrexia
Clinical narrative: stomach feels gassy; Diarrhea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), DIARRHOEA (Diarrhea) and FLATULENCE (stomach feels gassy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was not provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and PARACETAMOL (TYLENOL) for Headache, LOPERAMIDE HYDROCHLORIDE (IMODIUM) for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced PYREXIA (Fever). On 25-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced FLATULENCE (stomach feels gassy). On 25-Apr-2021, PYREXIA (Fever) outcome was unknown. At the time of the report, DIARRHOEA (Diarrhea) and FLATULENCE (stomach feels gassy) outcome was unknown. Not provided          No treatment information was provided. concomitant medications includes Gatorade and water   This case was linked to MOD-2021-114520 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Nonsignificant Followup Appended On 07-May-2021: Nonsignificant Followup Appended On 07-May-2021: AE Contact Information Updated
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling hot, Pyrexia
Clinical narrative: feels like her skin is on fire; fever (101.4 degrees Fahrenheit); This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008XZ1A and 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)). At the time of the report, FEELING HOT (feels like her skin is on fire) and PYREXIA (fever (101.4 degrees Fahrenheit)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4f (High) Body temperature-high.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. The patient took 2 tablets of Tylenol, to relieve the symptoms. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 99 degree temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (99 degree temperature) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (99 degree temperature). At the time of the report, PYREXIA (99 degree temperature) outcome was unknown. Not Provided          Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-114367 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114367:Case for mother
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Tired for couple of days with 1st dose Moderna COVID-19 Vaccine; Achy for couple of days with 1st dose Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired for couple of days with 1st dose Moderna COVID-19 Vaccine) and MYALGIA (Achy for couple of days with 1st dose Moderna COVID-19 Vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired for couple of days with 1st dose Moderna COVID-19 Vaccine) and MYALGIA (Achy for couple of days with 1st dose Moderna COVID-19 Vaccine). At the time of the report, FATIGUE (Tired for couple of days with 1st dose Moderna COVID-19 Vaccine) and MYALGIA (Achy for couple of days with 1st dose Moderna COVID-19 Vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Headache; Chills; Felt tired; Fever 101.3F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Felt tired), PYREXIA (Fever 101.3F) and HEADACHE (Headache) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA) for HIV pre-exposure prophylaxis, VITAMIN B2 [RIBOFLAVIN] for an unknown indication.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced CHILLS (Chills), FATIGUE (Felt tired) and PYREXIA (Fever 101.3F). On 18-Apr-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg. On 17-Apr-2021, PYREXIA (Fever 101.3F) had resolved. On 18-Apr-2021, CHILLS (Chills), FATIGUE (Felt tired) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 101.3 f (High) fever 101.3F.         This case was linked to MOD-2021-051612.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided          Concomitant medication was not provided. Treatment information was not provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest discomfort, Heart rate, Hypertension, Lymphadenopathy
Clinical narrative: funny sensation in chest; Sore Arm; blood pressure was measured at 155/88 mm Hg; Swollen left under arm lymph node; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was measured at 155/88 mm Hg), PAIN IN EXTREMITY (Sore Arm), CHEST DISCOMFORT (funny sensation in chest) and LYMPHADENOPATHY (Swollen left under arm lymph node) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL for Hypertension.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced HYPERTENSION (blood pressure was measured at 155/88 mm Hg) and LYMPHADENOPATHY (Swollen left under arm lymph node). On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On an unknown date, the patient experienced CHEST DISCOMFORT (funny sensation in chest). On 08-Apr-2021, HYPERTENSION (blood pressure was measured at 155/88 mm Hg) outcome was unknown. On 10-Apr-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. At the time of the report, CHEST DISCOMFORT (funny sensation in chest) outcome was unknown and LYMPHADENOPATHY (Swollen left under arm lymph node) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement: 153/72 mmHg (abnormal) 153/72 mmHg and 155/88 mmHg (abnormal) 155/88 mmHg. On 08-Apr-2021, Heart rate: heart beats per minute (abnormal) 60s-80s returned to normal 20 mins after vaccination.         Treatment medicines were not reported  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD21-054562, MOD21-054592, MOD21-054593.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up Information Received on 01-JUN-2021 contains No New Information On 09-Jun-2021: Non-significant Follow up received
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: funny sensation in chest; Sore Arm; blood pressure was measured at 155/88 mm Hg; Swollen left under arm lymph node; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was measured at 155/88 mm Hg), PAIN IN EXTREMITY (Sore Arm), CHEST DISCOMFORT (funny sensation in chest) and LYMPHADENOPATHY (Swollen left under arm lymph node) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATENOLOL for Hypertension.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced HYPERTENSION (blood pressure was measured at 155/88 mm Hg) and LYMPHADENOPATHY (Swollen left under arm lymph node). On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On an unknown date, the patient experienced CHEST DISCOMFORT (funny sensation in chest). On 08-Apr-2021, HYPERTENSION (blood pressure was measured at 155/88 mm Hg) outcome was unknown. On 10-Apr-2021, PAIN IN EXTREMITY (Sore Arm) had resolved. At the time of the report, CHEST DISCOMFORT (funny sensation in chest) outcome was unknown and LYMPHADENOPATHY (Swollen left under arm lymph node) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement: 153/72 mmHg (abnormal) 153/72 mmHg and 155/88 mmHg (abnormal) 155/88 mmHg. On 08-Apr-2021, Heart rate: heart beats per minute (abnormal) 60s-80s returned to normal 20 mins after vaccination.         Treatment medicines were not reported  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD21-054562, MOD21-054592, MOD21-054593.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up Information Received on 01-JUN-2021 contains No New Information On 09-Jun-2021: Non-significant Follow up received
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Blood pressure measurement, Feeling abnormal, Headache, Inappropriate schedule of product administration
Clinical narrative: Sick in the head; Floaty/shooting pain in my head; Patient has not schedule the second dose; Missed 2nd dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0281A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CYPROHEPTADINE HYDROCHLORIDE (PERIACTIN), ACETYLSALICYLIC ACID (BABY ASPIRIN), PANTOPRAZOLE and MONTELUKAST for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose). At the time of the report, FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose decreased: 50 (Low) Blood glucose went to 50. On an unknown date, Blood pressure measurement: 160 mmHg (High) Blood pressure was 160. On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up case received on 8-JUNE-2021 contains significant information.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional dose omission, SARS-CoV-2 test
Clinical narrative: Sick in the head; Floaty/shooting pain in my head; Patient has not schedule the second dose; Missed 2nd dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0281A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CYPROHEPTADINE HYDROCHLORIDE (PERIACTIN), ACETYLSALICYLIC ACID (BABY ASPIRIN), PANTOPRAZOLE and MONTELUKAST for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose). At the time of the report, FEELING ABNORMAL (Sick in the head), HEADACHE (Floaty/shooting pain in my head), BLOOD GLUCOSE DECREASED (Sugar went down to 50), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has not schedule the second dose) and INTENTIONAL DOSE OMISSION (Missed 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose decreased: 50 (Low) Blood glucose went to 50. On an unknown date, Blood pressure measurement: 160 mmHg (High) Blood pressure was 160. On an unknown date, SARS-CoV-2 test: positive (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up case received on 8-JUNE-2021 contains significant information.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Lethargy, Pyrexia
Clinical narrative: he did not even have a headache just a pulse of pain from sitting to standing which was so minor; a little lethargic; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness around the injection site), LETHARGY (a little lethargic), PYREXIA (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine), CHILLS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) and HYPERHIDROSIS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE PAIN (soreness around the injection site). On 07-May-2021, the patient experienced LETHARGY (a little lethargic), PYREXIA (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine), CHILLS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) and HYPERHIDROSIS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine). On 08-May-2021, the patient experienced HEADACHE (he did not even have a headache just a pulse of pain from sitting to standing which was so minor). On 08-May-2021, VACCINATION SITE PAIN (soreness around the injection site) had resolved. At the time of the report, LETHARGY (a little lethargic) and HEADACHE (he did not even have a headache just a pulse of pain from sitting to standing which was so minor) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD21-088377 (E2B Linked Report).; Sender's Comments:  MOD21-088377:Crosslink
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: he did not even have a headache just a pulse of pain from sitting to standing which was so minor; a little lethargic; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine; soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness around the injection site), LETHARGY (a little lethargic), PYREXIA (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine), CHILLS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) and HYPERHIDROSIS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE PAIN (soreness around the injection site). On 07-May-2021, the patient experienced LETHARGY (a little lethargic), PYREXIA (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine), CHILLS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine) and HYPERHIDROSIS (cycles of fevery chills that turned to profuse sweating for about an hour, was fine then fevery chills sweats and then fine). On 08-May-2021, the patient experienced HEADACHE (he did not even have a headache just a pulse of pain from sitting to standing which was so minor). On 08-May-2021, VACCINATION SITE PAIN (soreness around the injection site) had resolved. At the time of the report, LETHARGY (a little lethargic) and HEADACHE (he did not even have a headache just a pulse of pain from sitting to standing which was so minor) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD21-088377 (E2B Linked Report).; Sender's Comments:  MOD21-088377:Crosslink
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Axillary pain, Bone pain, Breast pain
Clinical narrative: bruise on the forearm; lump under the right armpit; chills (patient had to wear sweat pants); really bad bone pain; arms in a lot of pain radiating towards breast, then underneath armpits; arms in a lot of pain radiating towards breast, then underneath armpits; weak; loss of appetite; really tired; fatigue; nausea; pain in the right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) and CONTUSION (bruise on the forearm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included ASA for Anticoagulant therapy, LISINOPRIL for Blood pressure management.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (loss of appetite), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea) and ARTHRALGIA (pain in the right shoulder). On 08-May-2021, the patient experienced BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CHILLS (chills (patient had to wear sweat pants)) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits). On 09-May-2021, the patient experienced CONTUSION (bruise on the forearm) and MASS (lump under the right armpit). At the time of the report, ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CONTUSION (bruise on the forearm), MASS (lump under the right armpit), CHILLS (chills (patient had to wear sweat pants)), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea), ARTHRALGIA (pain in the right shoulder) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Ibuprofen and Tylenol.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Contusion, Decreased appetite, Fatigue
Clinical narrative: bruise on the forearm; lump under the right armpit; chills (patient had to wear sweat pants); really bad bone pain; arms in a lot of pain radiating towards breast, then underneath armpits; arms in a lot of pain radiating towards breast, then underneath armpits; weak; loss of appetite; really tired; fatigue; nausea; pain in the right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) and CONTUSION (bruise on the forearm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included ASA for Anticoagulant therapy, LISINOPRIL for Blood pressure management.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (loss of appetite), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea) and ARTHRALGIA (pain in the right shoulder). On 08-May-2021, the patient experienced BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CHILLS (chills (patient had to wear sweat pants)) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits). On 09-May-2021, the patient experienced CONTUSION (bruise on the forearm) and MASS (lump under the right armpit). At the time of the report, ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CONTUSION (bruise on the forearm), MASS (lump under the right armpit), CHILLS (chills (patient had to wear sweat pants)), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea), ARTHRALGIA (pain in the right shoulder) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Ibuprofen and Tylenol.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Nausea
Clinical narrative: bruise on the forearm; lump under the right armpit; chills (patient had to wear sweat pants); really bad bone pain; arms in a lot of pain radiating towards breast, then underneath armpits; arms in a lot of pain radiating towards breast, then underneath armpits; weak; loss of appetite; really tired; fatigue; nausea; pain in the right shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) and CONTUSION (bruise on the forearm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included ASA for Anticoagulant therapy, LISINOPRIL for Blood pressure management.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (loss of appetite), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea) and ARTHRALGIA (pain in the right shoulder). On 08-May-2021, the patient experienced BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CHILLS (chills (patient had to wear sweat pants)) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits). On 09-May-2021, the patient experienced CONTUSION (bruise on the forearm) and MASS (lump under the right armpit). At the time of the report, ASTHENIA (weak), DECREASED APPETITE (loss of appetite), BONE PAIN (really bad bone pain), BREAST PAIN (arms in a lot of pain radiating towards breast, then underneath armpits), CONTUSION (bruise on the forearm), MASS (lump under the right armpit), CHILLS (chills (patient had to wear sweat pants)), FATIGUE (really tired), FATIGUE (fatigue), NAUSEA (nausea), ARTHRALGIA (pain in the right shoulder) and AXILLARY PAIN (arms in a lot of pain radiating towards breast, then underneath armpits) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Ibuprofen and Tylenol.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Eye irritation, Fatigue, Feeling hot
Clinical narrative: eyes are burning; buckets of sweating; loss of appetite; not able to cool down; temperature doesn't regulate; tight when deep breathing; migraines; feeling tired; Temp 100.3F; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches) and EYE IRRITATION (eyes are burning) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004c21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ELETRIPTAN HYDROBROMIDE (RELPAX AXICORP) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches), EYE IRRITATION (eyes are burning), HYPERHIDROSIS (buckets of sweating), DYSPNOEA (tight when deep breathing), DECREASED APPETITE (loss of appetite), FEELING HOT (not able to cool down) and TEMPERATURE REGULATION DISORDER (temperature doesn't regulate). At the time of the report, FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches), EYE IRRITATION (eyes are burning), HYPERHIDROSIS (buckets of sweating), DYSPNOEA (tight when deep breathing), DECREASED APPETITE (loss of appetite), FEELING HOT (not able to cool down) and TEMPERATURE REGULATION DISORDER (temperature doesn't regulate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Treatment information was not provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Migraine, Myalgia, Pyrexia, Temperature regulation disorder
Clinical narrative: eyes are burning; buckets of sweating; loss of appetite; not able to cool down; temperature doesn't regulate; tight when deep breathing; migraines; feeling tired; Temp 100.3F; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches) and EYE IRRITATION (eyes are burning) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004c21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ELETRIPTAN HYDROBROMIDE (RELPAX AXICORP) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches), EYE IRRITATION (eyes are burning), HYPERHIDROSIS (buckets of sweating), DYSPNOEA (tight when deep breathing), DECREASED APPETITE (loss of appetite), FEELING HOT (not able to cool down) and TEMPERATURE REGULATION DISORDER (temperature doesn't regulate). At the time of the report, FATIGUE (feeling tired), MIGRAINE (migraines), PYREXIA (Temp 100.3F), MYALGIA (body aches), EYE IRRITATION (eyes are burning), HYPERHIDROSIS (buckets of sweating), DYSPNOEA (tight when deep breathing), DECREASED APPETITE (loss of appetite), FEELING HOT (not able to cool down) and TEMPERATURE REGULATION DISORDER (temperature doesn't regulate) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Ataxia, Hypoaesthesia, Muscular weakness, Vaccination site hypoaesthesia, Vaccination site movement impairment
Clinical narrative: numbness on left arm from injection site/ can't feel anything on arm; numbness on fingers; loss of muscle control; weakness of arm; can't hold onto objects tightly and will fall off hand/ no use of her left arm/ this has been on and off; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HYPOAESTHESIA (numbness on left arm from injection site/ can't feel anything on arm), HYPOAESTHESIA (numbness on fingers), ATAXIA (loss of muscle control), MUSCULAR WEAKNESS (weakness of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't hold onto objects tightly and will fall off hand/ no use of her left arm/ this has been on and off) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     Concomitant products included Atorvastatin for Cholesterol, Ibuprofen                                                      for tooth ache for Tooth ache, METFORMIN, Sarasiga, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE HYPOAESTHESIA (numbness on left arm from injection site/ can't feel anything on arm), HYPOAESTHESIA (numbness on fingers), ATAXIA (loss of muscle control), MUSCULAR WEAKNESS (weakness of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't hold onto objects tightly and will fall off hand/ no use of her left arm/ this has been on and off). At the time of the report, VACCINATION SITE HYPOAESTHESIA (numbness on left arm from injection site/ can't feel anything on arm), HYPOAESTHESIA (numbness on fingers), ATAXIA (loss of muscle control), MUSCULAR WEAKNESS (weakness of arm) and VACCINATION SITE MOVEMENT IMPAIRMENT (can't hold onto objects tightly and will fall off hand/ no use of her left arm/ this has been on and off) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took hot pack/warm compression on the arm as treatment information . Action taken with mRNA-1273 in response to the event was unknown
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Head titubation
Clinical narrative: Severe head tremors; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEAD TITUBATION (Severe head tremors) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included SIMVASTATIN for Cholesterol, OMEPRAZOLE for GERD, VALSARTAN for Hypertension, MELOXICAM for Pain.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced HEAD TITUBATION (Severe head tremors). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 12-Mar-2021, HEAD TITUBATION (Severe head tremors) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-114552 (Patient Link).
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Ear pain, Vaccination site lymphadenopathy
Clinical narrative: Left Ear Pain radiating to Left Shoulder; Swelling of Lymph Node Left Arm; Left Ear Pain radiating to Left Shoulder; This spontaneous case was reported by a pharmacist and describes the occurrence of the first episode of EAR PAIN (Left Ear Pain radiating to Left Shoulder), the second episode of EAR PAIN (Left Ear Pain radiating to Left Shoulder) and VACCINATION SITE LYMPHADENOPATHY (Swelling of Lymph Node Left Arm) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced the first episode of EAR PAIN (Left Ear Pain radiating to Left Shoulder) and VACCINATION SITE LYMPHADENOPATHY (Swelling of Lymph Node Left Arm). On 22-Apr-2021, the patient experienced the second episode of EAR PAIN (Left Ear Pain radiating to Left Shoulder). On 22-Apr-2021, last episode of EAR PAIN (Left Ear Pain radiating to Left Shoulder) outcome was unknown. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Swelling of Lymph Node Left Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Limb discomfort, Pain, Swelling
Clinical narrative: the ball reappeared, bigger,harder,ball hurts on pressing,small ball of liquid as if the vaccine were there; ball reappeared, this time it is bigger and harder; if pressed it the ball hurts; discomfort in her arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (the ball reappeared, bigger,harder,ball hurts on pressing,small ball of liquid as if the vaccine were there), INDURATION (ball reappeared, this time it is bigger and harder), PAIN (if pressed it the ball hurts) and LIMB DISCOMFORT (discomfort in her arm) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004621A and E31B21A) for COVID-19 vaccination.     No medical history information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced SWELLING (the ball reappeared, bigger,harder,ball hurts on pressing,small ball of liquid as if the vaccine were there), INDURATION (ball reappeared, this time it is bigger and harder), PAIN (if pressed it the ball hurts) and LIMB DISCOMFORT (discomfort in her arm). At the time of the report, SWELLING (the ball reappeared, bigger,harder,ball hurts on pressing,small ball of liquid as if the vaccine were there), INDURATION (ball reappeared, this time it is bigger and harder), PAIN (if pressed it the ball hurts) and LIMB DISCOMFORT (discomfort in her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was reported to take birth control pills. Upon internal review on 04-Aug-2021, age was corrected to 25 years.   This case was linked to MOD-2021-114521 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: chills; fatigue; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever). At the time of the report, CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Ibuprofen for symptoms relief.   This case was linked to US-MODERNATX, INC.-MOD-2021-114771 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-114771:Wife case
Sex: F
Vaccine: COVID19
Symptoms: Haematuria
Clinical narrative: Blood in her urine; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATURIA (Blood in her urine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAEMATURIA (Blood in her urine). At the time of the report, HAEMATURIA (Blood in her urine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles 5 weeks later after 2nd dose of Moderna COVID-19 Vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles 5 weeks later after 2nd dose of Moderna COVID-19 Vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021D21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles 5 weeks later after 2nd dose of Moderna COVID-19 Vaccine). The patient was treated with VALACYCLOVIR HYDROCHLORIDE for Shingles, at a dose of 1 gram three times a day. At the time of the report, HERPES ZOSTER (Shingles 5 weeks later after 2nd dose of Moderna COVID-19 Vaccine) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  The expiration date for second dose was provided as 9/26 (not sure if it was month and date). The patient got treated with Valacyclovir hydrochloride 1 gram tablet 3 times a day for 10 days.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Pain in extremity
Clinical narrative: expired vaccine was administered; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered) and PAIN IN EXTREMITY (sore arm) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 042B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered) and PAIN IN EXTREMITY (sore arm). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. Treatment medication reported includes Tylenol.